Literature DB >> 1873439

Follow-up of asymptomatic HTLV-I carriers among blood donors in Kyushu, Japan.

S Tokudome1, Y Maeda, K Fukada, D Teshima, T Asakura, E Sueoka, Y Motomura, Y Kusumoto, Y Imamura, T Kiyokawa.   

Abstract

We examined mortality from adult T-cell leukemia/lymphoma (ATL/ATLL) and other diseases alleged to be associated with human T-lymphotropic virus type I (HTLV-I) among anti-HTLV-I antibody-positive blood donors in Kyushu, Japan. During 1984-87, a total of 3,991 blood donors aged 40 years or over were followed from the date of donation to the date of death or the end of the study. Crude mortality rates from ATL (with 95 percent confidence intervals) were 68 per 100,000 (13-202) for males and 36 per 100,000 (3-132) for females. The rates were underestimated by approximately 50 percent because of self-selection and short observation periods. Neither death rates from other cancers nor death rates from all cancers were elevated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873439     DOI: 10.1007/bf00053124

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan.

Authors:  K Tajima; T Kuroishi
Journal:  Jpn J Clin Oncol       Date:  1985-06       Impact factor: 3.019

3.  Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

Authors:  E L Murphy; B Hanchard; J P Figueroa; W N Gibbs; W S Lofters; M Campbell; J J Goedert; W A Blattner
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

4.  Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan.

Authors:  S Tokudome; O Tokunaga; Y Shimamoto; Y Miyamoto; I Sumida; M Kikuchi; M Takeshita; T Ikeda; K Fujiwara; M Yoshihara
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

5.  Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers.

Authors:  T Kondo; H Kono; N Miyamoto; R Yoshida; H Toki; I Matsumoto; M Hara; H Inoue; A Inatsuki; T Funatsu
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

6.  HTLV-I seroprevalence in patients with malignancy.

Authors:  N Asou; T Kumagai; S Uekihara; M Ishii; M Sato; K Sakai; H Nishimura; K Yamaguchi; K Takatsuki
Journal:  Cancer       Date:  1986-08-15       Impact factor: 6.860

7.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

  8 in total
  2 in total

1.  Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.

Authors:  Tara Sefanya Kairupan; Rie Ibusuki; Motahare Kheradmand; Yasuko Sagara; Eva Mariane Mantjoro; Yora Nindita; Hideshi Niimura; Kazuyo Kuwabara; Shin Ogawa; Noriko Tsumematsu-Nakahata; Yasuhito Nerome; Tetsuhiro Owaki; Toshifumi Matsushita; Shigeho Maenohara; Kazunari Yamaguchi; Toshiro Takezaki
Journal:  J Epidemiol       Date:  2017-05-30       Impact factor: 3.211

2.  Mortality among inhabitants of an HTLV-I endemic area in Japan.

Authors:  K Iwata; S Ito; H Saito; M Ito; M Nagatomo; T Yamasaki; S Yoshida; H Suto; K Tajima
Journal:  Jpn J Cancer Res       Date:  1994-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.